Glenmede Trust CO Na Cytom X Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $6,961 - $8,500	-1,076 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$5.17 - $8.91 $956 - $1,648	185 Added 20.76%	1,076 $8,000
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $1,778 - $2,952	-241 Reduced 21.29%	891 $6,000
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $10,584 - $12,916	1,132 New	1,132 $12,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $79.1M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.